Navigation Links
Women for Women International Congolese Country Director, Christine Karumba, Speaks Out About the Rape Epidemic in the Democratic Republic of the Congo.
Date:10/9/2007

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- Girls as young as three and women as old as seventy-five have been raped and mutilated in Eastern Congo. "Women are dying two types of death," says Christine Karumba, Country Director, Women for Women International -- DRC. "The two types of death are the physical and the emotional death. The physical death is where you are no longer alive to walk the earth, and the emotional death is where you no longer see signs of hope and are dead inside."

Karumba has vivid recollection of growing up in the DRC and witnessing the trauma of living day by day not knowing if it was going to be your last became an everyday occurrence for many. The intensity and frequency of rape as a weapon of terror is worse than anywhere else in the world.

"Women are raped, mutilated and kept as sex slaves, then they are turned away from their families and left with no hope to rebuild their lives. Without hope, the women can not survive," says Karumba.

The United Nations reports 27,000 sexual assaults in 2006 in South Kivu Province alone, and Women for Women International estimates hundreds of thousands of women have been raped since the beginning of the conflict.

"Today in the villages where we work, women are still being raped. The difference is now women are talking about the rape and have a support network and hope," says Zainab Salbi Founder and CEO of Women for Women International.

Since 2004, Women for Women International has served 14,000 women and distributed $2.5 million in direct aid to the women of Eastern Congo. Women for Women International's holistic program addresses women's immediate economic and emotional needs and provides the job skills, health and literacy trainings to help women start small businesses and rebuild their lives.

In 2005 Women for Women International launched a Men's Leadership Program to train military, traditional and community leaders to use their social capital t
'/>"/>

SOURCE WOMEN FOR WOMEN INTERNATIONAL/ FENTON COMMUNICATIO
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Starvation in pregnant women can cause heart disease to their children
4. Women suffer from sexual dysfunction too
5. Brisk Walking lowers memory loss in women
6. Young womens woes
7. Young womens woes
8. Women find difficulty in calling it Quits
9. FDA approves new device to treat womens bleeding disorder
10. Women recognise faces better
11. Women more susceptible to brain damage from ecstasy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Pharmacy Technician Employment Increasing Up to 32% By 2016 2Antiabortion Advocate Appointed to Senior Position at HHS 48015 1Antiabortion Advocate Appointed to Senior Position at HHS 48015 2Special Ed Services Lacking for Kids Who Repeat a Grade 48011 1Special Ed Services Lacking for Kids Who Repeat a Grade 48011 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 1Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 3Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 4Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 5Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 6Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 7Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 8Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 9Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 10Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 11
Other Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6